Table 1. Biochemistry and anthropometric parameters in CAD cases vs. healthy controls in the entire study population reported in median (IQR)^† or mean (SD)^‡.

Parameters	Cases (n=83)	Controls (n=83)	P value
Age, years‡	51 (8.9)	50 (8.9)	0.49
Waist-Hip ratio‡	0.98 (0.05)	0.95 (0.06)	0.06
ApoA1, mg/dL†	115 [100–128]	136 [123–146]	<0.001
BMI‡	22.6 (2.6)	23.3 (3.4)	0.26
Systolic BP, mmHg†	130 [110–140]	120 [119–130]	0.05
Diastolic BP, mmHg†	80 [70–84]	80 [76–81]	0.46
Total cholesterol, mg/dL‡	188.5 [42]	189 [33]	0.93
Triglycerides, mg/dL†	141 [94–190]	123 [89–167]	0.03
LDL-C, mg/dL‡	117 [33]	123 [27]	0.29
HDL-C, mg/dL†	38 [36–42]	43 [39–45]	0.23
Non-HDL-C, mg/dL‡	146 [38]	147 [33]	0.82
VLDL-C, mg/dL†	28 [19–38]	25 [18–33]	0.03
ApoB, mg/dL†	85 [65–101]	90 [73–102]	0.31
ApoB/ApoA1†	0.76 (0.6–0.9)	0.68 (0.52–0.78)	0.003
Lp(a), mg/dL†	10.6 (4.6–25)	14.5 (5.5–25)	0.35
hs-CRP, mg/L†	2.4 (1.2–5.3)	1.6 (0.5–3.0)	0.01
Lp-PLA2 conc, ng/mL§†	253 [193–444]	246 [193–333]	0.05
Lp-PLA2 activity, nmol/min/mL†	154 [138–183]	166 [140–192]	0.12
TG/HDL-C ratio†	3.8 (2.2–5.3)	3 [2–4]	0.03
TC/HDL-C ratio†	4.6 (3.8–5.6)	4.7(4.0–5.5)	0.44

^†, Wilcoxon rank sum test for skewed distribution; reported in median (IQR); ^‡, paired t-test for normal distribution; reported in mean (SD); ^§, concentration also known as Lp-PLA₂ mass. Significant P values have been highlighted in italic. CAD, coronary artery disease; SD, standard deviation; IQR, interquartile range; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; VLDL-C, very low-density lipoprotein cholesterol; hs-CRP, high sensitivity C-reactive protein; Lp-PLA₂, lipoprotein associated phospholipase A₂.